Published in Neurobiol Aging on February 25, 2003
Linkage and association study of late-onset Alzheimer disease families linked to 9p21.3. Ann Hum Genet (2008) 1.09
Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome. J Clin Pathol (2005) 1.02
Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease. Aging (Albany NY) (2009) 1.01
Cell cycle activation and spinal cord injury. Neurotherapeutics (2011) 0.97
Mediator complex dependent regulation of cardiac development and disease. Genomics Proteomics Bioinformatics (2013) 0.90
Heritability and genetic association analysis of neuroimaging measures in the Diabetes Heart Study. Neurobiol Aging (2014) 0.83
The modular systems biology approach to investigate the control of apoptosis in Alzheimer's disease neurodegeneration. BMC Neurosci (2006) 0.80
Autism and intellectual disability in a patient with two microdeletions in 6q16: a contiguous gene deletion syndrome? Mol Cytogenet (2016) 0.75
Non-aggregated Aβ25-35 Upregulates Primary Astrocyte Proliferation In Vitro. Front Cell Neurosci (2017) 0.75
Regional patterns of gene expression in human and chimpanzee brains. Genome Res (2004) 3.84
A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice. Cell (2009) 3.63
The cholinergic system in aging and neuronal degeneration. Behav Brain Res (2010) 2.23
Tissue transglutaminase is not a biochemical marker for Alzheimer's disease. Neurobiol Aging (2013) 2.00
Serum lipids and hippocampal volume: the link to Alzheimer's disease? Ann Neurol (2004) 1.72
Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease. J Neurosci (2007) 1.52
Impact of cellular senescence signature on ageing research. Ageing Res Rev (2010) 1.47
Re-expression of cell cycle proteins induces neuronal cell death during Alzheimer's disease. J Alzheimers Dis (2002) 1.34
Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains. Cereb Cortex (2004) 1.14
Structural correlates of mild cognitive impairment. Neurobiol Aging (2004) 1.09
Different dendrite and dendritic spine alterations in basal and apical arbors in mutant human amyloid precursor protein transgenic mice. Brain Res (2006) 1.08
Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res (2002) 1.08
Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex. J Neuropathol Exp Neurol (2002) 1.07
Tau gene (MAPT) sequence variation among primates. Gene (2004) 1.06
Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains. Neurobiol Aging (2006) 1.05
AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. J Alzheimers Dis (2002) 1.05
Perineuronal nets potentially protect against oxidative stress. Exp Neurol (2004) 1.03
Tau oligomers impair artificial membrane integrity and cellular viability. J Biol Chem (2012) 1.03
Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons - implications for Alzheimer's disease. Eur J Neurosci (2007) 1.02
Neuroprotection against iron-induced cell death by perineuronal nets - an in vivo analysis of oxidative stress. Am J Neurodegener Dis (2012) 1.01
Involvement of perineuronal and perisynaptic extracellular matrix in Alzheimer's disease neuropathology. Brain Pathol (2012) 0.99
Systematic analysis of gene expression in human brains before and after death. Genome Biol (2005) 0.98
Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex. Neurobiol Dis (2004) 0.96
Expression of embryonic tau protein isoforms persist during adult neurogenesis in the hippocampus. Hippocampus (2007) 0.94
Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection. J Virol (2009) 0.94
Inducible neuronal expression of transgenic TGF-beta1 in vivo: dissection of short-term and long-term effects. Eur J Neurosci (2005) 0.94
Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study. J Neural Transm (Vienna) (2011) 0.94
Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation. J Biol Chem (2006) 0.92
The physiological link between metabolic rate depression and tau phosphorylation in mammalian hibernation. PLoS One (2011) 0.91
Expression of cell cycle-related proteins in developing and adult mouse hippocampus. Int J Dev Neurosci (2005) 0.91
Complementary distribution of vesicular glutamate transporters 1 and 2 in the nucleus accumbens of rat: Relationship to calretinin-containing extrinsic innervation and calbindin-immunoreactive neurons. J Comp Neurol (2003) 0.90
Neurochemical mapping of the human hippocampus reveals perisynaptic matrix around functional synapses in Alzheimer's disease. Acta Neuropathol (2012) 0.90
Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells. J Neurosci Res (2006) 0.90
A putative role for cell cycle-related proteins in microtubule-based neuroplasticity. Eur J Neurosci (2009) 0.89
Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease. J Neuroinflammation (2005) 0.89
Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus. Acta Neuropathol (2002) 0.88
Theta-power differences in patients with mild cognitive impairment under rest condition and during haptic tasks. Alzheimer Dis Assoc Disord (2002) 0.87
The expression of wild-type human amyloid precursor protein affects the dendritic phenotype of neocortical pyramidal neurons in transgenic mice. Int J Dev Neurosci (2005) 0.86
Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease. Ann N Y Acad Sci (2005) 0.86
Degeneration of beta-amyloid-associated cholinergic structures in transgenic APP SW mice. Brain Res (2003) 0.86
Age-dependent changes of glyoxalase I expression in human brain. Neurobiol Aging (2005) 0.85
Smad2 isoforms are differentially expressed during mouse brain development and aging. Int J Dev Neurosci (2009) 0.85
Pattern of tau isoforms expression during development in vivo. Int J Dev Neurosci (2009) 0.85
Altered subcellular location of phosphorylated Smads in Alzheimer's disease. Eur J Neurosci (2006) 0.85
Amyloid deposition in APP23 mice is associated with the expression of cyclins in astrocytes but not in neurons. Acta Neuropathol (2003) 0.85
Constitutive expression of functionally active cyclin-dependent kinases and their binding partners suggests noncanonical functions of cell cycle regulators in differentiated neurons. Cereb Cortex (2006) 0.84
Changes in neuronal DNA content variation in the human brain during aging. Aging Cell (2012) 0.84
Degeneration of cholinergic rat basal forebrain neurons after experimental subarachnoid hemorrhage. Neurosurgery (2008) 0.84
The expression of cell cycle proteins in neurons and its relevance for Alzheimer's disease. Curr Drug Targets CNS Neurol Disord (2005) 0.84
Early neurone loss in Alzheimer's disease: cortical or subcortical? Acta Neuropathol Commun (2015) 0.83
Transgenic expression of human wild-type amyloid precursor protein decreases neurogenesis in the adult hippocampus. Hippocampus (2010) 0.83
The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal. Neurotox Res (2005) 0.83
Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Abeta pathology in Alzheimer's disease. Acta Neuropathol (2010) 0.83
The relationship between head size and intracranial volume in elderly subjects. Brain Res (2003) 0.83
Constitutive Ras activity induces hippocampal hypertrophy and remodeling of pyramidal neurons in synRas mice. J Neurosci Res (2004) 0.82
The unfolded protein response affects neuronal cell cycle protein expression: implications for Alzheimer's disease pathogenesis. Exp Gerontol (2006) 0.82
Enhanced Ras activity promotes spine formation in synRas mice neocortex. Neuroreport (2005) 0.81
Enhanced Ras activity in pyramidal neurons induces cellular hypertrophy and changes in afferent and intrinsic connectivity in synRas mice. Int J Dev Neurosci (2004) 0.81
Reelin-immunoreactive Cajal-Retzius cells: the entorhinal cortex in normal aging and Alzheimer's disease. Acta Neuropathol (2003) 0.81
Intraneuronal advanced glycation endproducts in presenilin-1 Alzheimer's disease. Neuroreport (2002) 0.81
Laser scanning cytometry in human brain slices. Cytometry A (2006) 0.80
Expression of the embryonal isoform (0N/3R) of the microtubule-associated protein tau in the adult rat central nervous system. J Comp Neurol (2010) 0.80
Perineuronal nets are largely unaffected in Alzheimer model Tg2576 mice. Neurobiol Aging (2008) 0.80
Multivariate analysis of differential lymphocyte cell cycle activity in Alzheimer's disease. Neurobiol Aging (2010) 0.80
Constitutive expression of p21H-ras(Val12) in pyramidal neurons results in reorganization of mouse neocortical afferents. J Neurobiol (2004) 0.80
Adaptive morphological changes of neocortical interneurons in response to enlarged and more complex pyramidal cells in p21H-Ras(Val12) transgenic mice. Brain Res Bull (2004) 0.78
Identification of AGE-modified proteins in SH-SY5Y and OLN-93 cells. Neurotox Res (2006) 0.78
Expression of constitutively active p21H-rasval12 in postmitotic pyramidal neurons results in increased dendritic size and complexity. J Comp Neurol (2003) 0.78
FAD-mutation of APP is associated with a loss of its synaptotrophic activity. Neurobiol Dis (2009) 0.78
Comparison of results of the CellTiter Blue, the tetrazolium (3-[4,5-dimethylthioazol-2-yl]-2,5-diphenyl tetrazolium bromide), and the lactate dehydrogenase assay applied in brain cells after exposure to advanced glycation endproducts. Toxicol In Vitro (2007) 0.78
Vesicular glutamate transporter 3-immunoreactive pericellular baskets ensheath a distinct population of neurons in the lateral septum. J Chem Neuroanat (2008) 0.78
Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy. J Chem Neuroanat (2005) 0.78
Morphometry of the amygdala in patients with questionable dementia and mild dementia. J Neurol Sci (2005) 0.78
Immunocytochemical evidence for the striatal nature of the rat lateral part of interstitial nucleus of the posterior limb of the anterior commissure (IPAC). J Chem Neuroanat (2002) 0.78
Transcriptional control of cell cycle-dependent kinase 4 by Smad proteins--implications for Alzheimer's disease. Neurobiol Aging (2012) 0.78
Differentially expressed cortical genes contribute to perivascular deposition in transgenic mice with inducible neuron-specific expression of TGF-beta1. Int J Dev Neurosci (2005) 0.78
Effects of wild-type and mutant human amyloid precursor protein on cortical afferent network. Neuroreport (2007) 0.78
On the quantification of intracellular proteins in multifluorescence-labeled rat brain slices using slide-based cytometry. Cytometry A (2011) 0.77
PHF-like tau phosphorylation in mammalian hibernation is not associated with p25-formation. J Neural Transm (Vienna) (2009) 0.77
Pin1 promotes degradation of Smad proteins and their interaction with phosphorylated tau in Alzheimer's disease. Neuropathol Appl Neurobiol (2014) 0.77
Distribution and classification of aggrecan-based extracellular matrix in the thalamus of the rat. J Neurosci Res (2010) 0.77
Vegetable stalk as a nidus for gallstone formation in a patient with a juxtapapillary duodenal diverticulum. Gastrointest Endosc (2002) 0.77
Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease. Acta Neuropathol (2015) 0.76
Activation of Ras in neurons modifies synaptic vesicle docking and release. Neuroreport (2004) 0.76
Deprivation-induced dendritic shrinkage might be oppositely affected by the expression of wild-type and mutated human amyloid precursor protein. J Neurosci Res (2009) 0.76
RVG peptide as transfection reagent for specific cdk4 gene silencing in vitro and in vivo. J Drug Target (2012) 0.76
Dephosphorylation of tau protein by calcineurin triturated into neural living cells. Cell Mol Neurobiol (2002) 0.76
Oval cell proliferation in p16INK4a expressing mouse liver is triggered by chronic growth stimuli. J Cell Mol Med (2007) 0.76
Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation. J Neural Transm (Vienna) (2008) 0.76
Hypoxic stress, brain vascular system, and β-amyloid: a primary cell culture study. Nutr Neurosci (2013) 0.76
The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD. Mol Neurobiol (2013) 0.75
Chondroitin sulfate proteoglycan-based extracellular matrix in chicken (Gallus domesticus) brain. Brain Res (2009) 0.75
Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts". Neurobiol Aging (2005) 0.75
Association Study of Genetic Variants in CDKN2A/CDKN2B Genes/Loci with Late-Onset Alzheimer's Disease. Int J Alzheimers Dis (2011) 0.75
[Galantamine, an acetylcholinesterase inhibitor with various actions]. Med Monatsschr Pharm (2004) 0.75
Simultaneous detection of tau phospho-epitopes with haptenylated antibodies. Neuroreport (2006) 0.75
The role of tissue transglutaminase (transglutaminase type II) for the intestinal manifestations of murine semi-allogenic graft-versus-host disease. J Autoimmun (2002) 0.75
An inexpensive technique for dot blotting in a 96-well format. Anal Biochem (2009) 0.75
Early clinical and molecular detection of Alzheimer's disease. Int J Alzheimers Dis (2011) 0.75
Constitutively enhanced p21Ras activity amplifies dendritic remodeling of hippocampal neurons during physical activity. Int J Dev Neurosci (2009) 0.75